Quick Comparison
| Phosphatidylserine | Sulbutiamine | |
|---|---|---|
| Half-Life | Not well-characterized orally; brain PS turns over slowly | 5 hours |
| Typical Dosage | Standard: 100-300 mg daily in 1-3 doses. Most studies use 300 mg daily. Soy-derived and sunflower-derived forms are both effective. Take with food for absorption. | Standard: 200-600 mg daily in 1-2 doses. Take with food (fat-soluble). Tolerance can develop with daily use — best cycled or used intermittently. |
| Administration | Oral (softgels, capsules). Soy-derived or sunflower-derived. Take with fat for absorption. | Oral (capsules, tablets). Fat-soluble — take with food. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
Phosphatidylserine
PS is a structural component of neuronal membranes, maintaining membrane fluidity and supporting receptor function, ion channel activity, and neurotransmitter release. It localizes preferentially to the inner leaflet of the plasma membrane via flippase enzymes (P4-ATPases), where it serves as a cofactor for protein kinase C (PKC) isoforms alpha, beta, and gamma — PKC activation phosphorylates substrates including MARCKS and GAP-43, critical for synaptic plasticity and memory consolidation. PS modulates the HPA axis via glucocorticoid receptor feedback, reducing cortisol by 15-30% in stressed individuals. It facilitates choline transport via high-affinity choline transporter (CHT1) into presynaptic terminals, supporting acetylcholine synthesis by choline acetyltransferase. PS also regulates NMDA receptor function and supports Na+/K+-ATPase activity. Downstream, PS enhances CREB phosphorylation and BDNF expression in hippocampal neurons.
Sulbutiamine
Sulbutiamine consists of two thiamine (vitamin B1) molecules connected by a disulfide bridge, conferring lipophilicity and efficient blood-brain barrier penetration via passive diffusion. In the brain, it is hydrolyzed to thiamine and increases thiamine diphosphate (TDP) levels—the cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase, enzymes critical for glucose metabolism and the Krebs cycle. Sulbutiamine upregulates D1 dopamine receptors in the prefrontal cortex, possibly through reduced receptor internalization or increased expression. It modulates glutamatergic transmission (affecting NMDA/AMPA receptor function) and enhances cholinergic transmission. The anti-fatigue and memory-enhancing effects likely stem from improved neuronal glucose oxidation, increased ATP production, and enhanced dopaminergic and cholinergic tone in cognitive circuits.
Risks & Safety
Phosphatidylserine
Common
Mild gastrointestinal discomfort, insomnia at high doses.
Serious
May interact with blood thinners.
Rare
Allergic reaction in soy-sensitive individuals (use sunflower-derived).
Sulbutiamine
Common
Headache, insomnia, irritability, nausea. Tolerance develops with daily use.
Serious
No serious adverse effects documented.
Rare
Skin rash, mood instability, agitation.
Full Profiles
Phosphatidylserine →
A phospholipid that constitutes 15% of the brain's total phospholipid pool and is concentrated in neuronal cell membranes. Phosphatidylserine (PS) supports memory, cognitive function, and cortisol regulation. It is the only nootropic with an FDA-qualified health claim: 'consumption may reduce the risk of cognitive dysfunction in the elderly.' Particularly effective for age-related cognitive decline.
Sulbutiamine →
A synthetic fat-soluble derivative of thiamine (vitamin B1) developed in Japan to treat chronic fatigue and asthenia. Unlike regular thiamine, sulbutiamine crosses the blood-brain barrier and significantly increases thiamine levels in the brain. It modulates dopaminergic, glutamatergic, and cholinergic systems, providing mild stimulation, improved memory, and reduced mental fatigue.